Certified by Founder Lodge 
                                        
                                        Andera Partners
 
                                                 France  -  Paris, Île-de-France 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $60,000,000
                                            8 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage over €3.6 billion in investments in life sciences (
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   SoniVie Ltd | 
                                                            January, 17 ,2023 | Series C | $60,000,000 | 
   BioVentrix | 
                                                            April, 14 ,2023 | Series A | $48,500,000 | 
   Ariceum Therapeutics | 
                                                            April, 19 ,2023 | Series A | $27,393,000 | 
   Evommune | 
                                                            April, 27 ,2023 | Series B | $50,000,000 | 
   mylight150 | 
                                                            December, 05 ,2023 | Unknown | $108,326,000 | 
   Grey Wolf Therapeutics | 
                                                            May, 23 ,2024 | Series B | $50,000,000 | 
   EG 427 | 
                                                            February, 20 ,2025 | Series B | $28,195,425 | 
   Tubulis GmbH | 
                                                            October, 16 ,2025 | Series C | $359,197,300 | 
                                                
  SoniVie Ltd
  BioVentrix
  Ariceum Therapeutics
  Evommune
  mylight150
  Grey Wolf Therapeutics
  EG 427
  Tubulis GmbH
Cherry Ventures
 
                                            
Blue Bear Capital
 
                                            
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)